Logo of biochemjBJ Latest papers and much more!
Biochem J. Jul 15, 1989; 261(2): 595–600.
PMCID: PMC1138866

Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver.


Inductions by perfluoro-octanoic acid (PFOA) of hepatomegaly, peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase were compared in liver between male and female rats. Marked inductions of these four parameters were seen concurrently in liver of male rats, whereas the inductions in liver of female rats were far less pronounced. The sex-related difference in the response of rat liver to PFOA was much more marked than that seen with p-chlorophenoxyisobutyric acid (clofibric acid) or 2,2'-(decamethylenedithio)diethanol (tiadenol). Hormonal manipulations revealed that this sex-related difference in the inductions is strongly dependent on sex hormones, namely that testosterone is necessary for the inductions, whereas oestradiol prevented the inductions by PFOA.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (943K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hawkins JM, Jones WE, Bonner FW, Gibson GG. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev. 1987;18(4):441–515. [PubMed]
  • Sharma R, Lake BG, Foster J, Gibson GG. Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship. Biochem Pharmacol. 1988 Apr 1;37(7):1193–1201. [PubMed]
  • Sharma R, Lake BG, Gibson GG. Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies. Biochem Pharmacol. 1988 Apr 1;37(7):1203–1206. [PubMed]
  • Kawashima Y, Hirose A, Kozuka H. Selective increase in acylation of 1-acylglycerophosphorylcholine in livers of rats and mice by peroxisome proliferators. Biochim Biophys Acta. 1984 Apr 18;793(2):232–237. [PubMed]
  • Katoh H, Nakajima S, Kawashima Y, Kozuka H, Uchiyama M. Induction of rat hepatic long-chain acyl-CoA hydrolases by various peroxisome proliferators. Biochem Pharmacol. 1984 Apr 1;33(7):1081–1085. [PubMed]
  • Svoboda D, Grady H, Azarnoff D. Microbodies in experimentally altered cells. J Cell Biol. 1967 Oct;35(1):127–152. [PMC free article] [PubMed]
  • Svoboda D, Azarnoff D, Reddy J. Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands. J Cell Biol. 1969 Mar;40(3):734–746. [PMC free article] [PubMed]
  • Osumi T, Hashimoto T. Enhancement of fatty acyl-CoA oxidizing activity in rat liver peroxisomes by di-(i-ethylhexyl)phthalate. J Biochem. 1978 May;83(5):1361–1365. [PubMed]
  • Mitchell FE, Price SC, Hinton RH, Grasso P, Bridges JW. Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol. 1985 Dec;81(3 Pt 1):371–392. [PubMed]
  • Gray RH, de la Iglesia FA. Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species. Hepatology. 1984 May-Jun;4(3):520–530. [PubMed]
  • Kawashima Y, Katoh H, Kozuka H. Sex-related difference in the effect of clofibric acid on induction of two novel long-chain acyl-CoA hydrolases in rat liver. Biochim Biophys Acta. 1982 Jul 20;712(1):48–56. [PubMed]
  • Reddy JK, Reddy MK, Usman MI, Lalwani ND, Rao MS. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Environ Health Perspect. 1986 Mar;65:317–327. [PMC free article] [PubMed]
  • Rao MS, Reddy JK. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis. 1987 May;8(5):631–636. [PubMed]
  • Ikeda T, Aiba K, Fukuda K, Tanaka M. The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J Biochem. 1985 Aug;98(2):475–482. [PubMed]
  • Pastoor TP, Lee KP, Perri MA, Gillies PJ. Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp Mol Pathol. 1987 Aug;47(1):98–109. [PubMed]
  • Clark LC, Jr, Becattini F, Kaplan S, Obrock V, Cohen D, Becker C. Perfluorocarbons having a short dwell time in the liver. Science. 1973 Aug 17;181(4100):680–682. [PubMed]
  • Lazarow PB, De Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2043–2046. [PMC free article] [PubMed]
  • Kawashima Y, Katoh H, Kozuka H. Differential effects of altered hormonal state on the induction of acyl-CoA hydrolases and peroxisomal beta-oxidation by clofibric acid. Biochim Biophys Acta. 1983 Feb 7;750(2):365–372. [PubMed]
  • Katoh H, Kawashima Y, Watanuki H, Kozuka H, Isono H. Effects of clofibric acid and tiadenol on cytosolic long-chain acyl-CoA hydrolase and peroxisomal beta-oxidation in liver and extrahepatic tissues of rats. Biochim Biophys Acta. 1987 Jul 31;920(2):171–179. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Reddy JK, Kumar NS. Stimulation of catalase synthesis and increase of carnitine acetyltransferase activity in the liver of intact female rats fed clofibrate. J Biochem. 1979 Mar;85(3):847–856. [PubMed]
  • Reddy JK, Azarnoff DL, Svoboda DJ, Prasad JD. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response. J Cell Biol. 1974 May;61(2):344–358. [PMC free article] [PubMed]
  • Mitchell AM, Lhuguenot JC, Bridges JW, Elcombe CR. Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol. 1985 Aug;80(1):23–32. [PubMed]
  • Elcombe CR, Mitchell AM. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. Environ Health Perspect. 1986 Dec;70:211–219. [PMC free article] [PubMed]
  • Maffei Facino R, Carini M, Tofanetti O. Carboxylic metabolites of tiadenol as "proximate" inducers of hepatic peroxisomal beta-oxidation activity. Pharmacol Res Commun. 1988 Apr;20(4):265–276. [PubMed]
  • Baldwin JR, Witiak DT, Feller DR. Disposition of clofibrate in the rat. Acute and chronic administration. Biochem Pharmacol. 1980 Dec 1;29(23):3143–3154. [PubMed]
  • Cayen MN, Ferdinandi ES, Greselin E, Robinson WT, Dvornik D. Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs. J Pharmacol Exp Ther. 1977 Jan;200(1):33–43. [PubMed]
  • Emudianughe TS, Caldwell J, Sinclair KA, Smith RL. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man. Drug Metab Dispos. 1983 Mar-Apr;11(2):97–102. [PubMed]
  • Hanhijärvi H, Ylinen M, Kojo A, Kosma VM. Elimination and toxicity of perfluorooctanoic acid during subchronic administration in the Wistar rat. Pharmacol Toxicol. 1987 Jul;61(1):66–68. [PubMed]
  • Lalwani ND, Fahl WE, Reddy JK. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochem Biophys Res Commun. 1983 Oct 31;116(2):388–393. [PubMed]
  • Lalwani ND, Alvares K, Reddy MK, Reddy MN, Parikh I, Reddy JK. Peroxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5242–5246. [PMC free article] [PubMed]
  • Milton MN, Elcombe CR, Kass GE, Gibson GG. Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidaemic drugs to liver homogenates. Biochem Pharmacol. 1988 Mar 1;37(5):793–798. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...